Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while delivering rapid remissions for hard‑to‑treat patients.
In this week’s edition of The Prototype, we look at using AI to find new drugs, quantum biotechnology, the ROI of generative AI and more.
Walmart this spring will roll out clinical research sites in a limited number of stores and former shuttered clinic sites in an effort to increase patient access.
PBM transparency reforms aim to lower drug costs, but their impact on competition depends on how they affect smaller and independent pharmacy benefit managers.
End of life decision making is not just about living wills. More important than specifying what you want is specifying who you want making decisions.
In a large study, almost 27.3% individuals reported they had some type of sleep disorder.
Daniel Nadler, the 42-year-old CEO and cofounder of OpenEvidence, is now worth $7.6 billion as his AI search tool surges in popularity among U.S. doctors.
In this week’s edition of InnovationRx, we look at why Yann LeCun’s AI startup is focused on healthcare, Epic’s new predictive tools, and more.
Measles is revealing fractures in our public health system and insurance disparities. Each case costs almost $250,000. Misinformation about vaccine safety is fueling the rise.
Electronic retinal implants such as the PRIMA system bypass damaged cells to restore partial central vision, bringing high‑tech artificial sight closer to everyday clinical reality.